Clinical Trial Update: Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs [NA]

View source ↗

Summary

Clinical trial update indicates Ivonescimab (AK112) combined with chemotherapy for leptomeningeal metastasis in non-small cell lung cancer after EGFR-TKI failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Ivonescimab (AK112) (ivonescimab)

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: NSCLC, Chemotherapy | NA | Status: NOT_YET_RECRUITING